Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus (Q90475352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

title

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Fan Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Yixin Xiao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Rufeng Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Bin Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Fumin Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Liyan Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Hangping Yao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

Nanping Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

publication date

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

Emerging Microbes & Infections

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

664-675

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32193996 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

14 April 2020

copyright license

start time

1 January 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

1 reference

12 December 2020

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion

1 reference

12 December 2020

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

12 December 2020

Universal primer set for the full-length amplification of all influenza A viruses

1 reference

12 December 2020

International Standards for the Control of Avian Influenza

1 reference

12 December 2020

An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol

1 reference

12 December 2020

An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses

1 reference

12 December 2020

A highly conserved neutralizing epitope on group 2 influenza A viruses

1 reference

12 December 2020

A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.

1 reference

12 December 2020

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

1 reference

12 December 2020

Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan.

1 reference

12 December 2020

Global alert to avian influenza virus infection: from H5N1 to H7N9

1 reference

12 December 2020

A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head

1 reference

12 December 2020

An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection

1 reference

12 December 2020

Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.

1 reference

12 December 2020

A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms

1 reference

12 December 2020

Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge

1 reference

12 December 2020

Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice

1 reference

12 December 2020

A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.

1 reference

12 December 2020

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

1 reference

12 December 2020

An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo

1 reference

12 December 2020

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

1 reference

12 December 2020

Characterization of Novel Reassortant Influenza A (H5N2) Viruses Isolated from Poultry in Eastern China, 2015.

1 reference

12 December 2020

Characterization of reassortant H1-subtype avian influenza viruses isolated from poultry in Zhejiang Province in China from 2013 to 2015.

1 reference

12 December 2020

Virulence of an H5N8 highly pathogenic avian influenza is enhanced by the amino acid substitutions PB2 E627K and HA A149V.

1 reference

12 December 2020

Evolutionary genotypes of influenza A (H7N9) viruses over five epidemic waves in China

1 reference

12 December 2020

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.

1 reference

12 December 2020

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

1 reference

12 December 2020

Human infection with H9N2 avian influenza in northern China

1 reference

12 December 2020

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice

1 reference

12 December 2020

Structural insight into a human neutralizing antibody against influenza virus H7N9.

1 reference

12 December 2020

Establishment of a multiplex real-time RT-PCR assay for rapid identification of H6 subtype avian influenza viruses.

1 reference

12 December 2020

New threats of H7N9 influenza virus: the spread and evolution of highly and low pathogenic variants with high genomic diversity in Wave Five.

1 reference

12 December 2020

Amino Acid Substitutions HA A150V, PA A343T, and PB2 E627K Increase the Virulence of H5N6 Influenza Virus in Mice.

1 reference

12 December 2020

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

1 reference

12 December 2020

Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.

1 reference

12 December 2020

Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs

1 reference

12 December 2020

Antigenic Drift of H7N9 Viral Hemagglutinin

1 reference

12 December 2020

Amino acid residue 217 in the hemagglutinin glycoprotein is a key mediator of avian influenza H7N9 virus antigenicity

1 reference

12 December 2020

Molecular characterization of H10 subtype avian influenza viruses isolated from poultry in Eastern China

1 reference

12 December 2020

Isolation and characterization of novel reassortant H6N1 avian influenza viruses from chickens in Eastern China

1 reference

12 December 2020

Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40

1 reference

12 December 2020

State of the Art in Respiratory Syncytial Virus Drug Discovery and Development

1 reference

12 December 2020

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans

1 reference

12 December 2020

Influenza: annual seasonal severity

1 reference

12 December 2020

Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017

1 reference

12 December 2020

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

1 reference

12 December 2020

Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus

1 reference

12 December 2020

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model

1 reference

12 December 2020

Genetic diversity and host adaptation of avian H5N1 influenza viruses during human infection

1 reference

12 December 2020

The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019.

1 reference

12 December 2020

Current and novel approaches in influenza management

1 reference

12 December 2020

Introducing the new anti-influenza drug, baloxavir marboxil

1 reference

12 December 2020